S&P 500
5,966.05
+0.1%
+7.67
DJI
42,801.89
+0.3%
+147.15
NASDAQ
19,222.58
+0.1%
+11.48
Bitcoin
105,241.00
-0.4%
-408.88
AAPL
$209.00
-1.1%
-$2.26
AMZN
$206.46
+0.4%
+$0.87
GOOG
$167.17
-0.2%
-$0.26
META
$641.00
+0.1%
+$0.66
MSFT
$459.01
+1.0%
+$4.74
NVDA
$135.53
+0.1%
+$0.13
TSLA
$342.11
-2.2%
-$7.87
Poseida Therapeutics (NASDAQ: PSTX)
Some price data may be temporarily unavailable.
Poseida Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Poseida Therapeutics Company Info
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.